Endocarditis after closure of ventricular septal defect by transcatheter device.
Advances in interventional cardiology have enabled the treatment of severe congenital heart defects without the need for surgery. The percutaneous closure of atrial septal defects and, more recently, ventricular septal defects is considered a safe procedure with fewer complications and less morbidity compared with surgery. We report on a 2-year-old child who developed endocarditis after ventricular septal defect closure with an Amplatzer device. The patient recovered after intravenous antibiotics and anticoagulation. To the best of our knowledge, this is the first report of endocarditis associated with ventricular septal defect closure device insertion.
Scheuerman
Oded
O
Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel. odedshv@clalit.org.il
Bruckheimer
Elchanan
E
Marcus
Nufar
N
Hoffer
Vered
V
Garty
Ben-Zion
BZ
D006328:Cardiac Catheterization; D004697:Endocarditis, Bacterial / Q000209:etiology*; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000628:therapy*; D006801:Humans; D007223:Infant; D017881:Kingella; D016870:Neisseriaceae Infections / Q000209:etiology*; D019736:Prostheses and Implants / Q000009:adverse effects*; D016459:Prosthesis-Related Infections / Q000209:etiology*